Marceila de Andrade

Prevention of skin reactions due to teletherapy in women with breast cancer: a comprehensive review.

Teleterapia esta entre las modalidades de tratamiento para el cancer y uno de sus principales efectos adversos son reacciones de la piel, comunmente llamado radiodermatitis. Este estudio objetivo analizar el conocimiento acerca de los productos topicos utilizados para la prevencion de la radiodermatitis que justifiquen la atencion en teleterapia en mujeres con cancer de mama. Se adopto como metodo de investigacion la revision integradora de la literatura. Para la seleccion de los articulos se utilizaron cuatro bases de datos. La muestra fue constituida por 15 articulos. Los datos muestran que entre los productos topicos analizados la calendula, esteroides y Clair X tuvo un efecto protector significativo, destacando asi por sus acciones. La ausencia de articulos publicados en Brasil se centra en la necesidad de seguir investigando para mejorar la calidad de la atencion mediante el uso de productos con una eficacia cientificamente probada.One of the possible courses of cancer treatment is teletherapy, and one of the most important adverse side effects are skin reactions, an ailment more commonly called radiodermatitis. The main purpose of this study is to analyze knowledge of the evidence about topical products used in the prevention of radiodermatitis, to support care delivery to women with breast cancer during teletherapy. The research method used here is the comprehensive literature review. Four databases were used to select the bibliography. The sample consists of 15 articles. The data shows that, among the topical products analyzed here, Calendula, corticosteroids and Xclair have shown significant protective effects, underlining their actions. The lack of articles published in Brazil highlights the need for further research in this area, seeking better care quality through the use of products with scientifically proven efficiency.

Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy

Objectives to identify the prevalence, and describe the management of, neutropenia throughout the chemotherapy treatment among women with breast cancer. Methods observational study, cycles of chemotherapy. 116 neutropenic events were recorded, and 63.3% of the patients presented neutropenia at some point of their treatment, 46.5% of these presenting grade II. The management used was temporary suspension between the cycles and the mean number of delays was 6 days. The study was prospective and longitudinal, where the evaluation of the hematological toxicities was undertaken at each cycle of chemotherapy, whether neoadjuvant or adjuvant. Results 79 women were included, who received 572 cycles. However, the reasons for the suspensions were the lack of a space in the chemotherapy center, followed by neutropenia. Conclusion neutropenia is one of the most common and serious adverse events observed during the chemotherapy. Nursing must invest in research regarding this adverse event and in management strategies for organizing the public health system, so as to offer quality care.

Ocorrência e manejo de feridas neoplásicas em mulheres com câncer de mama avançado

Objective: To characterize the socio-demographic profile of women with breast cancer who present neoplastic wounds, and to identify the dressings used most for treating these wounds. Methods: This study has a quantitative approach, is cross-sectional and retrospective. The data was collected through a review of hospital records of women with breast cancer in the period 2000-2011. Results: The sample was constituted of 62 women with a mean age of 55.4 years old; 75.8% were white, 55% had invasive ductal carcinoma and 27.4% were in clinical stage IIIb. Of the deaths recorded, 27% occurred in less than 1 year after the appearance of the wound. The symptoms recorded were pain (32.2%), bleeding (35%) and necrosis (21%). The products used were silver sulfadiazine (23%) and Essential Fatty Acid (EFA) (16.1%). Conclusion: The results point to a lack of systematization of nursing care related to oncological wounds in this service.

Prevenção de reações de pele devido à teleterapia em mulheres com câncer de mama: revisão integrativa

Teleterapia esta entre las modalidades de tratamiento para el cancer y uno de sus principales efectos adversos son reacciones de la piel, comunmente llamado radiodermatitis. Este estudio objetivo analizar el conocimiento acerca de los productos topicos utilizados para la prevencion de la radiodermatitis que justifiquen la atencion en teleterapia en mujeres con cancer de mama. Se adopto como metodo de investigacion la revision integradora de la literatura. Para la seleccion de los articulos se utilizaron cuatro bases de datos. La muestra fue constituida por 15 articulos. Los datos muestran que entre los productos topicos analizados la calendula, esteroides y Clair X tuvo un efecto protector significativo, destacando asi por sus acciones. La ausencia de articulos publicados en Brasil se centra en la necesidad de seguir investigando para mejorar la calidad de la atencion mediante el uso de productos con una eficacia cientificamente probada.One of the possible courses of cancer treatment is teletherapy, and one of the most important adverse side effects are skin reactions, an ailment more commonly called radiodermatitis. The main purpose of this study is to analyze knowledge of the evidence about topical products used in the prevention of radiodermatitis, to support care delivery to women with breast cancer during teletherapy. The research method used here is the comprehensive literature review. Four databases were used to select the bibliography. The sample consists of 15 articles. The data shows that, among the topical products analyzed here, Calendula, corticosteroids and Xclair have shown significant protective effects, underlining their actions. The lack of articles published in Brazil highlights the need for further research in this area, seeking better care quality through the use of products with scientifically proven efficiency.

Neutropenia: ocurrencia y manejo en mujeres con cáncer de mama en quimioterapia

Objectives to identify the prevalence, and describe the management of, neutropenia throughout the chemotherapy treatment among women with breast cancer. Methods observational study, cycles of chemotherapy. 116 neutropenic events were recorded, and 63.3% of the patients presented neutropenia at some point of their treatment, 46.5% of these presenting grade II. The management used was temporary suspension between the cycles and the mean number of delays was 6 days. The study was prospective and longitudinal, where the evaluation of the hematological toxicities was undertaken at each cycle of chemotherapy, whether neoadjuvant or adjuvant. Results 79 women were included, who received 572 cycles. However, the reasons for the suspensions were the lack of a space in the chemotherapy center, followed by neutropenia. Conclusion neutropenia is one of the most common and serious adverse events observed during the chemotherapy. Nursing must invest in research regarding this adverse event and in management strategies for organizing the public health system, so as to offer quality care.

Neutropenia: ocorrência e manejo em mulheres com câncer de mama em quimioterapia

Objectives to identify the prevalence, and describe the management of, neutropenia throughout the chemotherapy treatment among women with breast cancer. Methods observational study, cycles of chemotherapy. 116 neutropenic events were recorded, and 63.3% of the patients presented neutropenia at some point of their treatment, 46.5% of these presenting grade II. The management used was temporary suspension between the cycles and the mean number of delays was 6 days. The study was prospective and longitudinal, where the evaluation of the hematological toxicities was undertaken at each cycle of chemotherapy, whether neoadjuvant or adjuvant. Results 79 women were included, who received 572 cycles. However, the reasons for the suspensions were the lack of a space in the chemotherapy center, followed by neutropenia. Conclusion neutropenia is one of the most common and serious adverse events observed during the chemotherapy. Nursing must invest in research regarding this adverse event and in management strategies for organizing the public health system, so as to offer quality care.

Occurrence and management of neoplastic wounds in women with advanced breast cancer

Objective: To characterize the socio-demographic profile of women with breast cancer who present neoplastic wounds, and to identify the dressings used most for treating these wounds. Methods: This study has a quantitative approach, is cross-sectional and retrospective. The data was collected through a review of hospital records of women with breast cancer in the period 2000-2011. Results: The sample was constituted of 62 women with a mean age of 55.4 years old; 75.8% were white, 55% had invasive ductal carcinoma and 27.4% were in clinical stage IIIb. Of the deaths recorded, 27% occurred in less than 1 year after the appearance of the wound. The symptoms recorded were pain (32.2%), bleeding (35%) and necrosis (21%). The products used were silver sulfadiazine (23%) and Essential Fatty Acid (EFA) (16.1%). Conclusion: The results point to a lack of systematization of nursing care related to oncological wounds in this service.

Ocurrencia y gestión de heridas neoplásicas en mujeres con cáncer de mama avanzado

Objective: To characterize the socio-demographic profile of women with breast cancer who present neoplastic wounds, and to identify the dressings used most for treating these wounds. Methods: This study has a quantitative approach, is cross-sectional and retrospective. The data was collected through a review of hospital records of women with breast cancer in the period 2000-2011. Results: The sample was constituted of 62 women with a mean age of 55.4 years old; 75.8% were white, 55% had invasive ductal carcinoma and 27.4% were in clinical stage IIIb. Of the deaths recorded, 27% occurred in less than 1 year after the appearance of the wound. The symptoms recorded were pain (32.2%), bleeding (35%) and necrosis (21%). The products used were silver sulfadiazine (23%) and Essential Fatty Acid (EFA) (16.1%). Conclusion: The results point to a lack of systematization of nursing care related to oncological wounds in this service.

Prevención de las reacciones en la piel debido a teleterapia en mujeres con cáncer de mama: revisión integradora

Teleterapia esta entre las modalidades de tratamiento para el cancer y uno de sus principales efectos adversos son reacciones de la piel, comunmente llamado radiodermatitis. Este estudio objetivo analizar el conocimiento acerca de los productos topicos utilizados para la prevencion de la radiodermatitis que justifiquen la atencion en teleterapia en mujeres con cancer de mama. Se adopto como metodo de investigacion la revision integradora de la literatura. Para la seleccion de los articulos se utilizaron cuatro bases de datos. La muestra fue constituida por 15 articulos. Los datos muestran que entre los productos topicos analizados la calendula, esteroides y Clair X tuvo un efecto protector significativo, destacando asi por sus acciones. La ausencia de articulos publicados en Brasil se centra en la necesidad de seguir investigando para mejorar la calidad de la atencion mediante el uso de productos con una eficacia cientificamente probada.One of the possible courses of cancer treatment is teletherapy, and one of the most important adverse side effects are skin reactions, an ailment more commonly called radiodermatitis. The main purpose of this study is to analyze knowledge of the evidence about topical products used in the prevention of radiodermatitis, to support care delivery to women with breast cancer during teletherapy. The research method used here is the comprehensive literature review. Four databases were used to select the bibliography. The sample consists of 15 articles. The data shows that, among the topical products analyzed here, Calendula, corticosteroids and Xclair have shown significant protective effects, underlining their actions. The lack of articles published in Brazil highlights the need for further research in this area, seeking better care quality through the use of products with scientifically proven efficiency.